REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Trioplus Pharmaceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: Trioplus Pharmaceuticals Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Trioplus Pharmaceuticals Private Limited is an enterprise located in India, with the main office in Mumbai. It operates in the Other Business Support Services industry. The company was established on July 23, 2013. The company’s latest financial report indicates a net sales revenue drop of 46.66% in 2023. Over the same period, its total assets decreased by 32.31%.

Legal Address
Unit No.106, Samruddhi Commercial Complex, Chincholi Bunder Road, Mindspace, Malad(West),
Mumbai; Maharashtra; Postal Code: 400064

Contact Details: Purchase the Trioplus Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Trioplus Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Trioplus Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
July 23, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Trioplus Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-46.66%▼
Total Operating Revenue
-47.71%▼
Operating Profit
N/A
EBITDA
-89.46%▼
Net Profit/Loss for the Period
N/A
Total Assets
-32.31%▼
Total Equity
-1.09%▼
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-31%▼
Quick Ratio
0.49%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo